Introduction: Hypertensive disorders represent the most frequent and serious complications of pregnancy and childbirth. Abnormal findings upon uterine artery Doppler, including altered values of pulsatility index and average persistence of bilateral diastolic notch, have been proposed as suitable predictors of preeclampsia in screening tests. Objectives: To evaluate the usefulness of uterine artery Doppler in predicting the occurrence of preeclampsia in a group of women at clinical and epidemiological risk for its development. Patients and methods: 81 pregnant women, all of which with risk factors for developing preeclampsia were selected. The average pulsatility index exams were performed on gestational intervals of 16+0 and 19+6 weeks and 24+0 and 27+6 weeks. In the latter range, the persistence of bilateral diastolic notch was also assessed. Results: Bilateral diastolic notch between 24+0 and 27+6 weeks of gestation could predict the diagnosis of preeclampsia with 75% sensitivity, 82% specificity, positive predictive value of 50% and negative predictive value of 93%. The analysis of data obtained between 16+0 and 19+6 weeks and between 24+0 and 27+6 weeks demonstrated that high values of mean pulsatility index were found in patients affected by preeclampsia compared with those found in the group of normotensive patients. Conclusion: pregnancies complicated by preeclampsia had significantly higher prevalence of bilateral notches and higher mean pulsatility indexes in each of the ranges studied. Since no specific treatment is currently available, the ability to predict the disease at its onset, in the first half of pregnancy, can facilitate early monitoring, increased support, and the ability to intervene at the appropriate time so as to reduce the maternal-fetal morbidity and mortality observed in preeclampsia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.